The 2024 Zaki study did show 2.5mm outperformed 1.5mm for atrophic acne scars, but with significantly more downtime and erythema
On This Page Indications and Usage Dosage and Administration Dosage Forms and Strengths Contraindications Warnings and Precautions Adverse Reactions/Side Effects Drug Interactions Use In Specific Populations Drug Abuse and Dependence Overdosage Description Clinical Pharmacology Nonclinical Toxicology Clinical Studies How Supplied/Storage and Handling Storage and Handling Patient Counseling Information Medication Guide Highlights of Prescribing Information VYVANSE (lisdexamfetamine dimesylate) capsules, for oral use, CII VYVANSE (lisdexamfetamine dimesylate) chewable tablets, for oral use, CII Initial U.S
The same goes for people who previously stopped GLP-1 therapy because of side effects and are considering trying again
[2] A Quiet but Important FDA Move On April 30, 2026, the FDA announced a proposal that did not generate much mainstream news coverage
Marc Jean-Gilles, DO, FACOG , at Abundant Life Healthcare for proper guidance and treatment